Suppr超能文献

外科医生经验在经尿道膀胱肿瘤切除结果中的作用。

Role of surgeon experience in the outcome of transurethral resection of bladder tumors.

作者信息

Ali Mohamed Hassan, Eltobgy Ahmed, Ismail Iman Yehia, Ghobish Ammar

机构信息

Department of Urology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

出版信息

Urol Ann. 2020 Oct-Dec;12(4):341-346. doi: 10.4103/UA.UA_138_19. Epub 2020 Oct 15.

Abstract

PURPOSE

The purpose of the study is to assess the quality of transurethral resection of bladder tumors (TURBTs) performed by "senior" and "junior" urologists in terms of detrusor muscle (DM) presence at the initial resection and presence of missed and residual tumors at second-look TURBT.

PATIENTS AND METHODS

An analytic prospective cohort study included 171 patients with stage T1 and Ta bladder cancer who had undergone an initial TURBT. Patients were divided into two groups according to surgeon experience. Group 1 (116 patients) operated on by senior surgeons (consultants and trainees in year 5 or 6) and Group 2 (55 patients) operated on by junior surgeons (trainees below year 5). All patients underwent second-look TURBT (by a senior urologist) within 2-6 weeks after the initial resection. The outcome of the initial and re-TURBT represented with regard to the surgeon experience.

RESULTS

There is a statistically significant difference between senior and junior surgeons regarding the presence or absence of DM in the initial resection ( = 0.001). A significant relation between the presence of residual tumors in re thermodynamic uncertainty relation (TUR) in relation to the initial operator was found ( = 0.03). Re-TURBT of patients in Group 1 (initially operated on by experienced surgeons) revealed that 57.7% had tumor-free resection while 36.2% had residual tumors, 5.2% had missed lesion and only 0.9% had concurrent residual and missed tumors. In contrast, from Group 2 (55 patients operated by junior surgeons) 47.3% had residual tumor, 21.8% had missed lesions, and 9.1% had concurrent residual and missed tumors in re-TUR.

CONCLUSIONS

Nonmuscle invasive bladder cancer treated with TURBT should be managed as any other major oncologic procedure. TURBT should be performed by an experienced surgeon or with very close supervision when done by training urologist.

摘要

目的

本研究旨在评估“资深”和“初级”泌尿外科医生进行经尿道膀胱肿瘤切除术(TURBT)的质量,评估指标包括初次切除时逼尿肌(DM)的存在情况以及二次经尿道膀胱肿瘤切除术时漏诊和残留肿瘤的情况。

患者与方法

一项分析性前瞻性队列研究纳入了171例T1期和Ta期膀胱癌患者,这些患者均接受了初次TURBT。根据外科医生的经验将患者分为两组。第1组(116例患者)由资深外科医生(顾问医生以及第5或6年的实习医生)进行手术,第2组(55例患者)由初级外科医生(第5年以下的实习医生)进行手术。所有患者在初次切除术后2 - 6周内接受二次经尿道膀胱肿瘤切除术(由资深泌尿外科医生进行)。根据外科医生的经验呈现初次和再次TURBT的结果。

结果

资深和初级外科医生在初次切除时DM的有无方面存在统计学显著差异(P = 0.001)。发现再次经尿道膀胱肿瘤切除术(TUR)中残留肿瘤的存在与初次手术医生之间存在显著关联(P = 0.03)。第1组(最初由经验丰富的外科医生进行手术)患者的再次TURBT显示,57.7%的患者切除无肿瘤,36.2%有残留肿瘤,5.2%有漏诊病变,仅有0.9%同时存在残留和漏诊肿瘤。相比之下,第2组(55例由初级外科医生进行手术的患者)在再次TUR中,47.3%有残留肿瘤,21.8%有漏诊病变,9.1%同时存在残留和漏诊肿瘤。

结论

采用TURBT治疗的非肌层浸润性膀胱癌应如同其他重大肿瘤手术一样进行管理。TURBT应由经验丰富的外科医生进行,或者在泌尿外科实习医生进行手术时进行非常密切的监督。

相似文献

1
Role of surgeon experience in the outcome of transurethral resection of bladder tumors.
Urol Ann. 2020 Oct-Dec;12(4):341-346. doi: 10.4103/UA.UA_138_19. Epub 2020 Oct 15.
4
Surgeon experience in second-look transurethral resection of bladder cancer - a prospective study.
Actas Urol Esp (Engl Ed). 2024 Jul-Aug;48(6):448-453. doi: 10.1016/j.acuroe.2023.12.007. Epub 2023 Dec 29.
6
Repeated transurethral resection for non-muscle invasive bladder cancer.
Int J Clin Exp Med. 2015 Jan 15;8(1):1416-9. eCollection 2015.
8
10

本文引用的文献

1
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
2
International variations in bladder cancer incidence and mortality.
Eur Urol. 2014 Jul;66(1):59-73. doi: 10.1016/j.eururo.2013.10.001. Epub 2013 Oct 16.
4
Management of non-muscle-invasive (superficial) bladder cancer.
Semin Oncol. 2012 Oct;39(5):559-72. doi: 10.1053/j.seminoncol.2012.08.001.
5
The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
BJU Int. 2012 Jul;110(2 Pt 2):E76-9. doi: 10.1111/j.1464-410X.2011.10904.x. Epub 2012 Feb 7.
7
Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer.
J Endourol. 2010 Dec;24(12):2047-50. doi: 10.1089/end.2010.0319. Epub 2010 Oct 8.
8
Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives.
Eur Urol. 2010 Aug;58(2):191-2. doi: 10.1016/j.eururo.2010.04.019. Epub 2010 Apr 21.
10
Quality control in transurethral resection of bladder tumours.
BJU Int. 2008 Nov;102(9 Pt B):1242-6. doi: 10.1111/j.1464-410X.2008.07966.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验